3D Images generated from PET/CT scans help surgeons envision tumours
Researchers at Jefferson Medical College in Philadelphia have developed a hologram-like display of a patient
Researchers at Jefferson Medical College in Philadelphia have developed a hologram-like display of a patient
Twenty grams of essential amino acids taken twice daily for a week before and for two weeks after knee-replacement surgeries helped 16 patients, mean age 69, recover faster and with much less muscle atrophy than a control group ingesting a placebo.
The approach could spell relief and speed recovery for a growing population of ageing adults who face total knee-replacements because of loss of mobility and pain problems. An estimated 3.48 million Americans are projected to need the surgery, known as total knee arthroplasty (TKA), by 2030.
The findings are part of an ongoing collaboration led by Hans C. Dreyer, a professor of human physiology at the University of Oregon, with the Eugene-based Slocum Research & Education Foundation and the Oregon Research Institute.
Atrophy in the quadriceps, a group of four muscles on the front of the thigh, has been a long-running problem following knee-replacement surgeries, Dreyer said.
In the study, 12 members of a control group receiving 40 grams a day of a non-essential amino acid supplement, a placebo, averaged an 18.4 loss in quadriceps muscle mass in their operated leg six weeks after surgery; those getting the supplement of eight essential amino acids (EEA) averaged a 6.2 percent loss. Eighty percent of atrophy occurred in the first two weeks after surgery. Atrophy in non-operative legs was about 50 percent of that in the operative leg in both groups. Muscle mass changes were seen with magnetic resonance imaging done at two and six weeks after surgery.
‘We’ve learned that the essential amino acids were able to mitigate the amount of muscle loss,’ Dreyer said. ‘The functional measures that we looked at
A new study suggests that people with obstructive sleep apnea (OSA) are perceived to appear more alert, more youthful and more attractive after at least two months of continuous positive airway pressure (CPAP) therapy.
‘This study showed that independent human raters
Dr Tom Lynch said the medical and IT worlds have come together to produce something unique. A group of medical consultants in Belfast have teamed up with IT specialists to develop a mobile app that can identify where a doctor is going wrong when interpreting X-rays. The app also helps medics develop their skills. It identifies areas of weakness that can be worked on in training and that could potentially save lives. According to those behind the training tool, it is the first of its kind in the world.
Dr Tom Lynch is among the founders. He said: ‘This is the medical and IT worlds coming together in Northern Ireland and producing something which is really unique.’
The app provides immediate feedback, and the more it is used by a doctor the more targeted and personalised the feedback becomes. Each doctor has particular strengths and weaknesses – this app means that the doctors are highlighted and then targeted. Primarily the device, known as Experior, will be used in accident and emergency and cancer departments, but could eventually be rolled out across all health specialities and even into education, industry and financial services.
BBC
The gelation tendencies of four bisphosphonates were studied in detail under the baton of Academy Research Fellow Elina Siev
Scientists have developed an
It
A new study shows that a neurologist in an office thousands of miles away can deliver effective specialized care to people with Parkinson
Scientists at A*STAR have discovered an enzyme, Wip1 phosphatase, as a potential target to weed out the progression of cancer. Although studies in the past have revealed that this enzyme plays a critical role in regulating the budding of tumours, scientists have for the first time unearthed a mechanism for its mode of action. The research was conducted by Dr Dmitry Bulavin and his team at A*STAR
Standard and reduced high-dose volume radiation therapy for muscle-invasive bladder cancer provide comparable tumour control and decreased late toxicity when compared to surgery, according to a study. The research is part of the United Kingdom
April 2024
The medical devices information portal connecting healthcare professionals to global vendors
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
Accept settingsHide notification onlyCookie settingsWe may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.
Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.
We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.
We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.
.These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.
If you do not want us to track your visit to our site, you can disable this in your browser here:
.
We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page
Google Webfont Settings:
Google Maps Settings:
Google reCaptcha settings:
Vimeo and Youtube videos embedding:
.U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.
Privacy policy